Attached files
| file | filename |
|---|---|
| EX-23.1 - EXHIBIT 23.1 12.31.19 - BIO-RAD LABORATORIES, INC. | ex231123119.htm |
| 10-K - 10-K 12.31.19 - BIO-RAD LABORATORIES, INC. | a10k123119.htm |
| EX-4.1 - EXHIBIT 4.1 12.31.19 - BIO-RAD LABORATORIES, INC. | ex41123119.htm |
| EX-21.1 - EXHIBIT 21.1 12.31.19 - BIO-RAD LABORATORIES, INC. | ex211123119.htm |
| EX-31.2 - EXHIBIT 31.2 CFO SECTION 302 CERTIFICATION - BIO-RAD LABORATORIES, INC. | ex312123119.htm |
| EX-32.1 - EXHIBIT 32.1 CEO SECTION 906 CERTIFICATION - BIO-RAD LABORATORIES, INC. | ex321123119.htm |
| EX-31.1 - EXHIBIT 31.1 CEO SECTION 302 CERTIFICATION - BIO-RAD LABORATORIES, INC. | ex311123119.htm |
Exhibit 32.2
Certification of Periodic Report
I, Ilan Daskal, Chief Financial Officer of Bio-Rad Laboratories, Inc. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:
(1) | the Annual Report on Form 10-K of the Company for the year ended December 31, 2019 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m); and |
(2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: | February 28, 2020 | /s/ Ilan Daskal | |
Ilan Daskal, Executive Vice President, | |||
Chief Financial Officer | |||
The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not being filed as part of the Annual Report or as a separate disclosure document.